✦ LIBER ✦

Circulating pro- and anti-angiogenic mediators in patients infected with hepatitis C at different stages of hepatocellular carcinoma

✍ Scribed by Talaat, Roba M.; Salem, Tarek A.; El-Masry, Samir; Imbarek, Arafat; Mokhles, Mohamed; Abdel-Aziz, Amal

Book ID: 124076427
Publisher: John Wiley and Sons
Year: 2014
Tongue: English
Weight: 729 KB
Volume: 86
Category: Article
ISSN: 0146-6615
DOI: 10.1002/jmv.23932

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Previous or Occult Hepatitis B Virus Inf

Previous or Occult Hepatitis B Virus Infection in Hepatitis B Surface Antigen-Negative and Anti-Hepatitis C-Negative Patients with Hepatocellular Carcinoma

✍ Kazuki Ohba; Shoji Kubo; Akihiro Tamori; Kazuhiro Hirohashi; Hiromu Tanaka; Taic 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 325 KB

CD81 nucleotide mutation in hepatocellul

CD81 nucleotide mutation in hepatocellular carcinoma and lack of CD81 polymorphism in patients at stages of hepatitis C virus infection

✍ Jun Itakura; Kazuyoshi Nagayama; Nobuyuki Enomoto; Naoya Sakamoto; Junichi Tazaw 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 526 KB

Mechanisms determining the chronicity or the pattern of clinical course of hepatitis C virus (HCV) infections have not been clarified. Recently, CD81 was reported to bind the E2 protein of HCV and was suggested to function as a cellular receptor for HCV. Accordingly, the hypothesis was examined that

Differences in molecular alterations of

Differences in molecular alterations of hepatocellular carcinoma between patients with a sustained virological response and those with hepatitis C virus infection

✍ Takehiro Hayashi; Akihiro Tamori; Manabu Nishikawa; Hiroyasu Morikawa; Masaru En 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

Characteristics and outcome of patients

Characteristics and outcome of patients with dual hepatitis B and C-associated hepatocellular carcinoma: are they different from patients with single virus infection?

✍ Teh-Ia Huo; Yi-Hsiang Huang; Cheng-Yuan Hsia; Chien-Wei Su; Han-Chieh Lin; Chia- 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Expression of bile duct-type cytokeratin

Expression of bile duct-type cytokeratin in hepatocellular carcinoma in patients with hepatitis C virus and prior hepatitis B virus infection

✍ Takahiro Uenishi; Shoji Kubo; Kazuhiro Hirohashi; Takatsugu Yamamoto; Masao Ogaw 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 369 KB

Varying incidence of cirrhosis and hepat

Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy

✍ Michiko Shindo; Arai Ken; Tadao Okuno 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 3 views

## BACKGROUND. To determine whether interferon (IFN) therapy can reduce incidence of the development of cirrhosis and hepatocellular carcinoma equally in patients with chronic hepatitis C virus (HCV) who responded differently to therapy, a retrospective analysis of 250 patients treated with IFN wa